HomeInsightsShare Holding

Piramal Pharma Ltd Share Holding Pattern

Piramal Pharma Ltd Share Holding Pattern

stocks purchased

₹ 10.6 Cr

Volume Transacted

(Nov 12, 2024)

stocks purchased

423.2 K

Stocks Traded

(Nov 12, 2024)

Last Updated on: Nov 12, 2024

Promoters Holdings Over Time

Key Highlights

  • FIIs/FPIs increased their stake in the company by 0.83% from March 2024 to June 2024. Mutual funds increased their stake in the company by 1.11% from March 2024 to June 2024.
  • Promoters decreased their stake in the company by 0.07% from March 2024 to June 2024.

Latest Shareholding

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Nov 2024250.55
11 Nov 2024269.65
08 Nov 2024281.8
07 Nov 2024292.1
06 Nov 2024293.55
05 Nov 2024273.6
04 Nov 2024275.75
01 Nov 2024281.85
31 Oct 2024268.4
30 Oct 2024252.35

Piramal Pharma Ltd News Hub

News

Piramal Pharma hits life high on reporting multi-fold jump in Q2 PAT

Revenue from operations grew by 17.28% year on year (YoY) to Rs 2,241.75 crore during the ...

Read more

24 Oct 202412:32

News

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October ...

Read more

15 Oct 202410:20

News

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Or...

Read more

30 Sep 202418:48

News

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets ini...

Read more

17 Sep 202410:14

News

Piramal Pharma grants 48.30 lakh stock options

Piramal Pharma has granted 48,30,836 stock options under Employee Stock Option and Incenti...

Read more

26 Jul 202410:05

News

Piramal Pharma Q1 net loss narrows to Rs 89 crore

Revenue from operations grew by 11.57% year on year (YoY) to Rs 1,951.14 crore during the ...

Read more

26 Jul 202414:28

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

TranscriptPPT

Feb 2023

Transcript

Jan 2023

PPT

Nov 2022

Transcript

FAQs for EPS of Piramal Pharma Ltd

On what factors does the shareholding pattern of Piramal Pharma Ltd change frequently?

The shareholding pattern of Piramal Pharma Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Piramal Pharma Ltd's shareholding pattern updated?

The Piramal Pharma Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Piramal Pharma Ltd?

Categories included in the shareholding pattern of Piramal Pharma Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Piramal Pharma Ltd important for investors?

The shareholding pattern of Piramal Pharma Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Piramal Pharma Ltd?

The latest shareholding pattern of Piramal Pharma Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*